However, the data remains sparse, with only several smaller studies showing a plausible direct proportionality of a therapeutic effect across tumours
By utilizing the highly sensitive and drug-tolerant assays, we were able to comprehensively outline the characteristics of ADA against adalimumab, offering fresh insights into immunogenicity and its clinical implications
Current findings suggest potential for metabolic research, but not for routine clinical use
Ask your plan whether they require step therapy: trying less expensive alternatives first (metformin, sulfonylureas) before approving GLP-1s
For patients whose primary concern is hollowing in the cheeks, temples, or under-eye area, hyaluronic acid fillers can restore immediate volume